Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
118K
-
Shares change
-
-49K
-
Total reported value, excl. options
-
$814K
-
Value change
-
-$179K
-
Number of buys
-
4
-
Number of sells
-
-1
-
Price
-
$6.87
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q3 2025
8 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q3 2025.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118K shares
of 51.9M outstanding shares and own 0.23% of the company stock.
Largest 8 shareholders include Blue Trust, Inc. (69.1K shares), World Investment Advisors (34.3K shares), STRS OHIO (9.1K shares), MassMutual Private Wealth & Trust, FSB (4.82K shares), AMALGAMATED BANK (902 shares), GAMMA Investing LLC (102 shares), CWM, LLC (86 shares), and Perigon Wealth Management, LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.